A protein that has a metal ion cofactor is referred to as a "metalloprotein" in general. This group includes a sizable fraction of all proteins. For instance, although there may be up to 3000 human zinc metalloproteins, at least 1000 human proteins have zinc-binding protein domains. A metal is thought to be present in around half of all proteins. According to another estimate, between 25 and 30 percent of all proteins are thought to need metals in order to function. As a result, metalloproteins serve a variety of purposes in cells, including the storage and movement of proteins, the transportation of enzymes and signalling proteins, and the prevention of infectious illnesses. The prevalence of metal-binding proteins might be a natural consequence of the amino acids that proteins employ, as even synthetic proteins devoid of evolutionary history will readily bind metals. The majority of metals in the human body are linked to proteins. For instance, hemoglobin's iron content accounts for the majority of the body's relatively high iron concentration. Metal ions in metalloproteins are typically coordinated by nitrogen, oxygen, or sulphur centres located in the protein's amino acid residues. The side-chains on the amino acid residues frequently serve as these donor groups. The carboxylate groups that aspartate provides, the thiolate substituents in cysteine residues, and the imidazole substitutes in histidine residues are all particularly significant. Almost all amino acid residues have been demonstrated to bind metal centers, which is not surprising given the diversity of the metalloproteome. Deprotonated amides and amide carbonyl oxygen centres are two additional donor groups that are provided by the peptide backbone.
Title : Application of vanadium and tantalum single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Valorizing lignocellulose to Ethylene Glycol: Catalysis, catalyst deactivation and conceptual process design
Jean Paul Lange, University of Twente, Netherlands
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Design of nanocomposite materials for active components of structured catalysts for biofuels transformation into syngas, catalytic layers of membrane reactors with oxygen/hydrogen separation and anodes of solid oxide fuels cells operating in the internal reforming mode
Vladislav Sadykov, Boreskov Institute of Catalysis, Russian Federation
Title : Human impact on natural environment and its implications
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-inspired & biotech-driven translational applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Solar heterogeneous photocatalysis and photochemistry for urban wastewater regeneration and reuse
Isabel Oller Alberola, Plataforma Solar de AlmerÃa, Spain
Title : Distal functionalization via transition metal catalysis
Haibo Ge, Texas Tech University, United States
Title : Effect of bed material on syngas quality: Comparison of biomass gasification with different bed materials
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Production of nanocomposites from wastes to remove the pollutants
Delia Teresa Sponza, Dokuz Eylul University, Turkey